No Detail Found!

Linezolid Study on Isolates of Staphylococcus aureus and Escherichia coli Through Disc Diffusion Method.

Author(s)
Syed Akif Uddin Department of Pharmaceutics, Federal Urdu University, Karachi, Pakistan
Lubna Bashir Department of Pharmaceutics, Federal Urdu University, Karachi, Pakistan
Shazia Naz Department of Pharmaceutics, Federal Urdu University, Karachi, Pakistan
Humera Naz Reign Pharmaceuticals Pvt. Ltd, Karachi, Pakistan
Saima Yasin Baig Department of Pharmaceutical Chemistry, Federal Urdu University, Karachi, Pakistan
Abstract
Objective: The objective of this study was to evaluate the effectiveness of Linezolid on Staphylococcus aureus and Escherichia coli through disc diffusion method. Methods: Discs of Linezolid were used for the evaluation of antibacterial activity of the Linezolid. Antibacterial activity was investigated against gram positive Staphylococcus aureus and gram negative Escherichia coli. The disc content of Linezolid was composed of 30 µg. Results: The antimicrobial susceptibility test demonstrated that Linezolid was effective against Staphylococcus aureus and Escherichia coli. Two isolates of Staphylococcus aureus showed susceptibility (zones were found 26mm and 22mm), while one of the isolates of Escherichia coli showed susceptibility and the other showed resistance (zones were found 21mm and 18mm, respectively). Conclusion: It is concluded that Linezolid have better antibacterial activity on Staphylococcus aureus as well as on Escherichia coli so can be used in treatment of different infections.
Publication Details
Page(s) 264-269
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 6, Issue: 4, Year: 2018

Request the full text from PASTIC

Keywords
Escherichia coli, disc diffusion, oxazolidinone, linezolid
References
RangHP,DaleMM,RitterJM,FlowerRJ,HendersonG, 2012.Rang and Dale's Pharmacology, -
MaddisonJE,PageSW,ChurchDB, 2008.,Small Animal Clinical Pharmacology. Elsevier Health Sciences; -
ShawKJ,BarbachynMR, 2011.The oxazolidinones: past, present, and future,Ann NY Acad Sci 1241 48 -70
PrasantiKJ,SundarBS, 2012.A validated RP-HPLC method for the determination of linezolid in pharmaceutical dosage forms,Int J Pharm Bio Sci 3 44 -51
TsujiBT,KaatzGW,Rybak MJ,LLC, 2005.Linezolid and other oxazolidinones. Antimicrobial therapy and vaccines,Esun Technologies 223 -41
ZurenkoGE,YagiBH,SchaadtRD,AllisonJW,KilburnJO,GlickmanSE, 1996.novel oxazolidinone antibacterial agents,Antimicrob Agents Chemother 40 839 -45
MutnickAH,BiedenbachDJ,TurnidgeJD,JonesRN, 2002.Spectrum and potency evaluation of a new oxazolidinone,Diagn Microbiol Infect Dis 43 65 -73
SwaneySM, 1998.Oxazolidinone resistance is associated with a mutation in the peptidyl transferase region of 23S rRNA,In program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy 98 -9
PrystowskyJ,SiddiquiF,ChosayJ,ShinabargerDL,MillichapJ,PetersonLR, 2001.Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci,Antimicrob Agents Chemother 45 2154 -6
Aminov RI, 2010.A brief history of the antibiotic era: lessons learned and challenges for the future,Front Microbiol 134 -
MelakeaNA,ZakariabAS, 2012.In vitro activity of linezolid alone and in combination with glycopeptides against methicillin-resistant Staphylococcus aureus,Int Res J Microbiol 3 127 -35
Hamilton-MillerJM,Shah S, 1999.Susceptibility testing of linezolid by two standard methods,Eur J Clin Microbiol Infect Dis 18 225 -7
LalithaMK, 2004.Manual on antimicrobial susceptibility testing. Performance standards for antimicrobial testing: Twelfth Informational Supplement, 56238 454 -6
RuangpanL,TendenciaEA, 2004.Laboratory manual of standardized methods for antimicrobial sensitivity tests for bacteria isolated from aquatic animals and environment, -
BiedenbachDJ,JonesRN, 1997.Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents,J Clin Microbiol 35 3198 -202
RellerLB,WeinsteinM,JorgensenJH,Ferraro MJ, 2009.Antimicrobial susceptibility testing: a review of general principles and contemporary practices,Clin Infect Dis 49 1749 -55
Zahedi BialvaeiA,RahbarM,YousefiM,AsgharzadehM,Samadi Kafil H. Linezolid, 2017.: a promising option in the treatment of Grampositives,J Antimicrob Chemother 72 354 -64
StevensDL,SmithLG,BrussJB,McConnellMartinMA,DuvallSE,ToddWM, 2000.Randomized comparison of linezolid (PNU100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections,Antimicrob Agents Chemother 44 3408 -13
0

Citations

0

Downloads

115

Views